What’s New?
Find out what’s new in the lab on Social Media
Dr. Mathioudakis Featured Guest in Pain Matters Podcast on AI in Medicine
Together with Dr. Tinglong Tai from the Johns Hopkins Carey Business School, Dr. Mathioudakis was a featured guest in the Pain Matters Podcast discussing “The Future of AI in Medicine: Current State, Applications, and Evolution.” Tune in here.
Lab Member Wins Oral Presentation at Research Symposium
We are delighted to announce a remarkable achievement within our lab. Setu Mehta, a dedicated second-year medical student from Johns Hopkins, has been an integral part of our research team, focusing on the critical area of inpatient diabetes management. It is with great pride we share that Setu has been honored with the prestigious "Distinction in Medical Student Research Award for Oral Presentations" at the Medical Student Research Symposium. This accolade was bestowed upon her for her exceptional research project, which aimed to assess the impact of inpatient diabetes management services on glycemic control among hospitalized patients. Setu's project was distinguished by its methodological rigor and the clarity with which she communicated her findings, earning her the presentation one of the two winning spots in the public health category for oral presentations. This recognition not only highlights her commitment to advancing medical research but also underscores the importance of our lab's work in improving patient care outcomes in the realm of diabetes management.
International Consensus Report on Precision Medicine in Diabetes
Under the umbrella of the Precision Medicine in Diabetes Initiative (PMDI) and supported by renowned organizations like the ADA, EASD, and the Novo Nordisk Foundation, Dr. Mathioudakis served as a Co-Chair on an international consortium that brought together 200 academic experts from 28 countries. Dr. Mathioudakis led one of the working groups (precision prognostics for cardiovascular disease in type 2 diabetes) and is a lead author on the consensus report.
Key findings from the report include:
Major advancements in the adoption of precision medicine for diabetes diagnosis, treatment, prevention, and prognosis.
The essential role of precision medicine in accurately diagnosing and treating monogenic diabetes.
The promising potential of precision medicine in managing gestational diabetes and in the prevention of type 1 diabetes.
While this report showcases clear progress in the domain of precision diabetes medicine, it also emphasizes the critical knowledge gaps in the field. Read the full report here.
Mathioudakis Lab Featured by T1D Exchange
Research by the Mathioudakis lab was highlighted in a “Meet the Expert” piece by T1D Exchange. Another highlight in this artile “Juneteenth: A Critical Reminder that Black People with Diabetes Deserve Better Healthcare.”